PHAR vs MSFT: Which Stock is Better?
Side-by-side comparison of Pharming Group Nv and Microsoft Corp in 2026
PHAR
Pharming Group Nv
$17.34
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | PHAR | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.22B | N/A | PHAR |
| P/E Ratio | 433.25 | 26.32 | MSFT |
| EPS (TTM) | $0.04 | $15.97 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 87.9% | 68.6% | PHAR |
Analyze PHAR
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or MSFT a better investment?
Comparing PHAR and MSFT: Pharming Group Nv has a market cap of $1.22B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and MSFT?
PHAR (Pharming Group Nv) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (26.3x vs 433.3x).
Which is growing faster: PHAR or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for PHAR.
Which company is more profitable: PHAR or MSFT?
Pharming Group Nv (PHAR) has higher gross margins at 87.9% compared to 68.6% for MSFT.
Which is the larger company: PHAR or MSFT?
Pharming Group Nv (PHAR) is larger with a market cap of $1.22B compared to N/A for MSFT.
Should I buy PHAR or MSFT in 2026?
Both PHAR and MSFT have investment merit. PHAR trades at $17.34 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and MSFT stock?
Key differences: Market Cap ($1.22B vs N/A), P/E Ratio (433.3x vs 26.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (87.9% vs 68.6%).